Articles de revues sur le sujet « HIV (Viruses) Gene therapy »
Créez une référence correcte selon les styles APA, MLA, Chicago, Harvard et plusieurs autres
Consultez les 50 meilleurs articles de revues pour votre recherche sur le sujet « HIV (Viruses) Gene therapy ».
À côté de chaque source dans la liste de références il y a un bouton « Ajouter à la bibliographie ». Cliquez sur ce bouton, et nous générerons automatiquement la référence bibliographique pour la source choisie selon votre style de citation préféré : APA, MLA, Harvard, Vancouver, Chicago, etc.
Vous pouvez aussi télécharger le texte intégral de la publication scolaire au format pdf et consulter son résumé en ligne lorsque ces informations sont inclues dans les métadonnées.
Parcourez les articles de revues sur diverses disciplines et organisez correctement votre bibliographie.
Hu, JinTing, YeWen Feng, Ping Ma et Yu Lai. « Coreceptor-Based Hematopoietic Stem Cell Gene Therapy for HIV Disease ». Current Stem Cell Research & ; Therapy 14, no 7 (23 septembre 2019) : 591–97. http://dx.doi.org/10.2174/1574888x14666190523094556.
Weinberger, Leor S., David V. Schaffer et Adam P. Arkin. « Theoretical Design of a Gene Therapy To Prevent AIDS but Not Human Immunodeficiency Virus Type 1 Infection ». Journal of Virology 77, no 18 (15 septembre 2003) : 10028–36. http://dx.doi.org/10.1128/jvi.77.18.10028-10036.2003.
Das, Atze T., Thijn R. Brummelkamp, Ellen M. Westerhout, Monique Vink, Mandy Madiredjo, René Bernards et Ben Berkhout. « Human Immunodeficiency Virus Type 1 Escapes from RNA Interference-Mediated Inhibition ». Journal of Virology 78, no 5 (1 mars 2004) : 2601–5. http://dx.doi.org/10.1128/jvi.78.5.2601-2605.2004.
Bacheler, Lee, Susan Jeffrey, George Hanna, Richard D'Aquila, Lany Wallace, Kelly Logue, Beverly Cordova et al. « Genotypic Correlates of Phenotypic Resistance to Efavirenz in Virus Isolates from Patients Failing Nonnucleoside Reverse Transcriptase Inhibitor Therapy ». Journal of Virology 75, no 11 (1 juin 2001) : 4999–5008. http://dx.doi.org/10.1128/jvi.75.11.4999-5008.2001.
Sakkhachornphop, Supachai, Sudarat Hadpech, Tanchanok Wisitponchai, Chansunee Panto, Doungnapa Kantamala, Utaiwan Utaipat, Jutarat Praparattanapan et al. « Broad-Spectrum Antiviral Activity of an Ankyrin Repeat Protein on Viral Assembly against Chimeric NL4-3 Viruses Carrying Gag/PR Derived from Circulating Strains among Northern Thai Patients ». Viruses 10, no 11 (13 novembre 2018) : 625. http://dx.doi.org/10.3390/v10110625.
Manisha. B. Shinde, Dr. Archana D. Kajale, Dr. Madhuri A. Channawar et Dr. Shilpa R. Gawande. « Vector-mediated cancer gene therapy : A review ». GSC Biological and Pharmaceutical Sciences 13, no 2 (30 novembre 2020) : 152–65. http://dx.doi.org/10.30574/gscbps.2020.13.2.0368.
Martinez, Miguel Angel, Maria Nevot, Ana Jordan-Paiz et Sandra Franco. « Similarities between Human Immunodeficiency Virus Type 1 and Hepatitis C Virus Genetic and Phenotypic Protease Quasispecies Diversity ». Journal of Virology 89, no 19 (15 juillet 2015) : 9758–64. http://dx.doi.org/10.1128/jvi.01097-15.
Bailey, Justin R., Ahmad R. Sedaghat, Tara Kieffer, Timothy Brennan, Patricia K. Lee, Megan Wind-Rotolo, Christine M. Haggerty et al. « Residual Human Immunodeficiency Virus Type 1 Viremia in Some Patients on Antiretroviral Therapy Is Dominated by a Small Number of Invariant Clones Rarely Found in Circulating CD4+ T Cells ». Journal of Virology 80, no 13 (1 juillet 2006) : 6441–57. http://dx.doi.org/10.1128/jvi.00591-06.
Saunders, Kevin O., Lingshu Wang, M. Gordon Joyce, Zhi-Yong Yang, Alejandro B. Balazs, Cheng Cheng, Sung-Youl Ko et al. « Broadly Neutralizing Human Immunodeficiency Virus Type 1 Antibody Gene Transfer Protects Nonhuman Primates from Mucosal Simian-Human Immunodeficiency Virus Infection ». Journal of Virology 89, no 16 (3 juin 2015) : 8334–45. http://dx.doi.org/10.1128/jvi.00908-15.
Styczyński, Jan. « ABC of viral infections in hematology : focus on herpesviruses ». Acta Haematologica Polonica 50, no 3 (28 septembre 2019) : 159–66. http://dx.doi.org/10.2478/ahp-2019-0026.
Palker, T. J. « Human T-cell Lymphotropic Viruses : Review and Prospects for Antiviral Therapy ». Antiviral Chemistry and Chemotherapy 3, no 3 (juin 1992) : 127–39. http://dx.doi.org/10.1177/095632029200300301.
Appelt, Jens U., Frank A. Giordano, Marcel Zimmermann, Stephan Weinhard, Nadja Grund, Agnes Hotz-Wagenblatt, W. Jens Zeller, Heike Allgayer, Stefan Fruehauf et Stephanie Laufs. « Genes Involved in Acute Leukemias Are Favored Targets of HIV Vector Integration ». Blood 110, no 11 (16 novembre 2007) : 3738. http://dx.doi.org/10.1182/blood.v110.11.3738.3738.
Schopman, Nick C. T., Anja Braun et Ben Berkhout. « Directed HIV-1 Evolution of Protease Inhibitor Resistance by Second-Generation Short Hairpin RNAs ». Antimicrobial Agents and Chemotherapy 56, no 1 (7 novembre 2011) : 479–86. http://dx.doi.org/10.1128/aac.05491-11.
Martin, Supang A., Patricia A. Cane, Deenan Pillay et Jean L. Mbisa. « Coevolved Multidrug-Resistant HIV-1 Protease and Reverse Transcriptase Influences Integrase Drug Susceptibility and Replication Fitness ». Pathogens 10, no 9 (24 août 2021) : 1070. http://dx.doi.org/10.3390/pathogens10091070.
Tonkinson, J. L., et C. A. Stein. « Antisense Nucleic Acids — Prospects for Antiviral Intervention ». Antiviral Chemistry and Chemotherapy 4, no 4 (août 1993) : 193–200. http://dx.doi.org/10.1177/095632029300400401.
Kim, Sanggu, Yun-Cheol Kim, Hangfei Qi, Kunkai Su, Sherie L. Morrison et Samson A. Chow. « Efficient Identification of Human Immunodeficiency Virus Type 1 Mutants Resistant to a Protease Inhibitor by Using a Random Mutant Library ». Antimicrobial Agents and Chemotherapy 55, no 11 (29 août 2011) : 5090–98. http://dx.doi.org/10.1128/aac.00687-11.
Ahlenstiel, Golo, Kirsten Roomp, Martin Däumer, Jacob Nattermann, Martin Vogel, Jürgen K. Rockstroh, Niko Beerenwinkel et al. « Selective Pressures of HLA Genotypes and Antiviral Therapy on Human Immunodeficiency Virus Type 1 Sequence Mutation at a Population Level ». Clinical and Vaccine Immunology 14, no 10 (22 août 2007) : 1266–73. http://dx.doi.org/10.1128/cvi.00169-07.
Charpentier, Charlotte, Tamara Nora, Olivier Tenaillon, François Clavel et Allan J. Hance. « Extensive Recombination among Human Immunodeficiency Virus Type 1 Quasispecies Makes an Important Contribution to Viral Diversity in Individual Patients ». Journal of Virology 80, no 5 (1 mars 2006) : 2472–82. http://dx.doi.org/10.1128/jvi.80.5.2472-2482.2006.
Browning, Matthew T., Russell D. Schmidt, Kathy A. Lew et Tahir A. Rizvi. « Primate and Feline Lentivirus Vector RNA Packaging and Propagation by Heterologous Lentivirus Virions ». Journal of Virology 75, no 11 (1 juin 2001) : 5129–40. http://dx.doi.org/10.1128/jvi.75.11.5129-5140.2001.
Miyoshi, Hiroyuki, Ulrike Blömer, Masayo Takahashi, Fred H. Gage et Inder M. Verma. « Development of a Self-Inactivating Lentivirus Vector ». Journal of Virology 72, no 10 (1 octobre 1998) : 8150–57. http://dx.doi.org/10.1128/jvi.72.10.8150-8157.1998.
Boucher, C. A., W. Keulen, T. van Bommel, M. Nijhuis, D. de Jong, M. D. de Jong, P. Schipper et N. K. Back. « Human immunodeficiency virus type 1 drug susceptibility determination by using recombinant viruses generated from patient sera tested in a cell-killing assay. » Antimicrobial Agents and Chemotherapy 40, no 10 (octobre 1996) : 2404–9. http://dx.doi.org/10.1128/aac.40.10.2404.
Bacheler, Lee T., Elizabeth D. Anton, Phil Kudish, David Baker, Julie Bunville, Karen Krakowski, Laura Bolling et al. « Human Immunodeficiency Virus Type 1 Mutations Selected in Patients Failing Efavirenz Combination Therapy ». Antimicrobial Agents and Chemotherapy 44, no 9 (1 septembre 2000) : 2475–84. http://dx.doi.org/10.1128/aac.44.9.2475-2484.2000.
von Eije, Karin Jasmijn, Olivier ter Brake et Ben Berkhout. « Human Immunodeficiency Virus Type 1 Escape Is Restricted When Conserved Genome Sequences Are Targeted by RNA Interference ». Journal of Virology 82, no 6 (12 décembre 2007) : 2895–903. http://dx.doi.org/10.1128/jvi.02035-07.
Biswas, Preetha, Xi Jiang, Annmarie L. Pacchia, Joseph P. Dougherty et Stuart W. Peltz. « The Human Immunodeficiency Virus Type 1 Ribosomal Frameshifting Site Is an Invariant Sequence Determinant and an Important Target for Antiviral Therapy ». Journal of Virology 78, no 4 (15 février 2004) : 2082–87. http://dx.doi.org/10.1128/jvi.78.4.2082-2087.2004.
Salomon, H., Z. Gu, Q. Gao, K. Nagai, J. Hiscott et M. A. Wainberg. « Host Cell Dependence of Human Immunodeficiency Virus Type-1 Drug Resistance Profiles and Tissue Culture Selection Patterns ». Antiviral Chemistry and Chemotherapy 6, no 4 (août 1995) : 222–29. http://dx.doi.org/10.1177/095632029500600404.
Patton, Gillian S., Otto Erlwein et Myra O. McClure. « Cell-cycle dependence of foamy virus vectors ». Journal of General Virology 85, no 10 (1 octobre 2004) : 2925–30. http://dx.doi.org/10.1099/vir.0.80210-0.
Servais, Jean, Christine Lambert, Elodie Fontaine, Jean-Marc Plesséria, Isabelle Robert, Vic Arendt, Thérèse Staub et al. « Variant Human Immunodeficiency Virus Type 1 Proteases and Response to Combination Therapy Including a Protease Inhibitor ». Antimicrobial Agents and Chemotherapy 45, no 3 (1 mars 2001) : 893–900. http://dx.doi.org/10.1128/aac.45.3.893-900.2001.
Ariffin, Tengku Ahmad Akram Tengku Mohd, Suharni Mohamad, Wan Nazirah Wan Yusuf et Rafidah Hanim Shueb. « Antiretroviral drug resistance and HIV-1 subtypes among treatment-naive prisoners in Kelantan, Malaysia ». Journal of Infection in Developing Countries 8, no 08 (13 août 2014) : 1063–67. http://dx.doi.org/10.3855/jidc.4095.
Price, David A., George Scullard, Annette Oxenius, Ruth Braganza, Simon A. Beddows, Shamim Kazmi, John R. Clarke, Gabriele E. Johnson, Jonathan N. Weber et Rodney E. Phillips. « Discordant Outcomes following Failure of Antiretroviral Therapy Are Associated with Substantial Differences in Human Immunodeficiency Virus-Specific Cellular Immunity ». Journal of Virology 77, no 10 (15 mai 2003) : 6041–49. http://dx.doi.org/10.1128/jvi.77.10.6041-6049.2003.
Winters, M. A., R. W. Shafer, R. A. Jellinger, G. Mamtora, T. Gingeras et T. C. Merigan. « Human immunodeficiency virus type 1 reverse transcriptase genotype and drug susceptibility changes in infected individuals receiving dideoxyinosine monotherapy for 1 to 2 years. » Antimicrobial Agents and Chemotherapy 41, no 4 (avril 1997) : 757–62. http://dx.doi.org/10.1128/aac.41.4.757.
Vasudevachari, M. B., Y. M. Zhang, H. Imamichi, T. Imamichi, J. Falloon et N. P. Salzman. « Emergence of protease inhibitor resistance mutations in human immunodeficiency virus type 1 isolates from patients and rapid screening procedure for their detection. » Antimicrobial Agents and Chemotherapy 40, no 11 (novembre 1996) : 2535–41. http://dx.doi.org/10.1128/aac.40.11.2535.
Hoeben, RC, FJ Fallaux, SJ Cramer, DJ van den Wollenberg, H. van Ormondt, E. Briet et AJ van der Eb. « Expression of the blood-clotting factor-VIII cDNA is repressed by a transcriptional silencer located in its coding region ». Blood 85, no 9 (1 mai 1995) : 2447–54. http://dx.doi.org/10.1182/blood.v85.9.2447.bloodjournal8592447.
Susser, Simone, Mathieu Flinders, Henk W. Reesink, Stefan Zeuzem, Glenn Lawyer, Anne Ghys, Veerle Van Eygen, James Witek, Sandra De Meyer et Christoph Sarrazin. « Evolution of Hepatitis C Virus Quasispecies during Repeated Treatment with the NS3/4A Protease Inhibitor Telaprevir ». Antimicrobial Agents and Chemotherapy 59, no 5 (23 février 2015) : 2746–55. http://dx.doi.org/10.1128/aac.04911-14.
Persaud, Deborah, George K. Siberry, Aima Ahonkhai, Joleen Kajdas, Daphne Monie, Nancy Hutton, Douglas C. Watson, Thomas C. Quinn, Stuart C. Ray et Robert F. Siliciano. « Continued Production of Drug-Sensitive Human Immunodeficiency Virus Type 1 in Children on Combination Antiretroviral Therapy Who Have Undetectable Viral Loads ». Journal of Virology 78, no 2 (15 janvier 2004) : 968–79. http://dx.doi.org/10.1128/jvi.78.2.968-979.2004.
Goujon, Caroline, Loraine Jarrosson-Wuilleme, Jeanine Bernaud, Dominique Rigal, Jean-Luc Darlix et Andrea Cimarelli. « Heterologous Human Immunodeficiency Virus Type 1 Lentiviral Vectors Packaging a Simian Immunodeficiency Virus-Derived Genome Display a Specific Postentry Transduction Defect in Dendritic Cells ». Journal of Virology 77, no 17 (1 septembre 2003) : 9295–304. http://dx.doi.org/10.1128/jvi.77.17.9295-9304.2003.
Indriati, Dwi Wahyu, Tomohiro Kotaki, Siti Qamariyah Khairunisa, Adiana Mutamsari Witaningrum, Muhammad Qushai Yunifiar Matondang, Shuhei Ueda, Nasronudin, Asep Purnama, Dwi Kurniawan et Masanori Kameoka. « Appearance of Drug Resistance Mutations Among the Dominant HIV-1 Subtype, CRF01_AE in Maumere, Indonesia ». Current HIV Research 16, no 2 (15 août 2018) : 158–66. http://dx.doi.org/10.2174/1570162x16666180502114344.
Weber, Jan, Ana C. Vazquez, Dane Winner, Justine D. Rose, Doug Wylie, Ariel M. Rhea, Kenneth Henry et al. « Novel Method for Simultaneous Quantification of Phenotypic Resistance to Maturation, Protease, Reverse Transcriptase, and Integrase HIV Inhibitors Based on 3′Gag(p2/p7/p1/p6)/PR/RT/INT-Recombinant Viruses : a Useful Tool in the Multitarget Era of Antiretroviral Therapy ». Antimicrobial Agents and Chemotherapy 55, no 8 (31 mai 2011) : 3729–42. http://dx.doi.org/10.1128/aac.00396-11.
Kaltenbach, Robert F., George Trainor, Daniel Getman, Greg Harris, Sena Garber, Beverly Cordova, Lee Bacheler et al. « DPC 681 and DPC 684 : Potent, Selective Inhibitors of Human Immunodeficiency Virus Protease Active against Clinically Relevant Mutant Variants ». Antimicrobial Agents and Chemotherapy 45, no 11 (1 novembre 2001) : 3021–28. http://dx.doi.org/10.1128/aac.45.11.3021-3028.2001.
Lohrengel, Sabine, Felix Hermann, Isabel Hagmann, Heike Oberwinkler, Laura Scrivano, Caroline Hoffmann, Dorothee von Laer et Matthias T. Dittmar. « Determinants of Human Immunodeficiency Virus Type 1 Resistance to Membrane-Anchored gp41-Derived Peptides ». Journal of Virology 79, no 16 (15 août 2005) : 10237–46. http://dx.doi.org/10.1128/jvi.79.16.10237-10246.2005.
Pluta, Aneta, Juan P. Jaworski et César N. Cortés-Rubio. « Balance between Retroviral Latency and Transcription : Based on HIV Model ». Pathogens 10, no 1 (29 décembre 2020) : 16. http://dx.doi.org/10.3390/pathogens10010016.
Vassilopoulos, George, Grant Trobridge, Neil C. Josephson et David W. Russell. « Gene transfer into murine hematopoietic stem cells with helper-free foamy virus vectors ». Blood 98, no 3 (1 août 2001) : 604–9. http://dx.doi.org/10.1182/blood.v98.3.604.
Holterman, Lennart, Ronald Vogels, Remko van der Vlugt, Martijn Sieuwerts, Jos Grimbergen, Jorn Kaspers, Eric Geelen et al. « Novel Replication-Incompetent Vector Derived from Adenovirus Type 11 (Ad11) for Vaccination and Gene Therapy : Low Seroprevalence and Non-Cross-Reactivity with Ad5 ». Journal of Virology 78, no 23 (1 décembre 2004) : 13207–15. http://dx.doi.org/10.1128/jvi.78.23.13207-13215.2004.
Hill, Claire L., Paul D. Bieniasz et Myra O. McClure. « Properties of human foamy virus relevant to its development as a vector for gene therapy ». Journal of General Virology 80, no 8 (1 août 1999) : 2003–9. http://dx.doi.org/10.1099/0022-1317-80-8-2003.
Swan, Christina H., Bernd Buhler, Mario P. Tschan, Carlos F. Barbas et Bruce E. Torbett. « Lentiviral CCR5 Intrabody Gene Delivery Provides Protection and Enrichment during CCR5-Tropic Infection. » Blood 104, no 11 (16 novembre 2004) : 1755. http://dx.doi.org/10.1182/blood.v104.11.1755.1755.
White, Sarah M., Matthew Renda, Na-Yon Nam, Ekaterina Klimatcheva, Yonghong Zhu, Jennifer Fisk, Mark Halterman et al. « Lentivirus Vectors Using Human and Simian Immunodeficiency Virus Elements ». Journal of Virology 73, no 4 (1 avril 1999) : 2832–40. http://dx.doi.org/10.1128/jvi.73.4.2832-2840.1999.
Gu, Zhengxian, Hengsheng Fang, Horacio Salomon, Qing Gao et Mark A. Wainberg. « Identification of Mutations that Encode Drug Resistance in the Polymerase Gene of the Human Immunodeficiency Virus ». Canadian Journal of Infectious Diseases 5, suppl e (1994) : 29E—33E. http://dx.doi.org/10.1155/1994/826340.
De Bolle, Leen, Lieve Naesens et Erik De Clercq. « Update on Human Herpesvirus 6 Biology, Clinical Features, and Therapy ». Clinical Microbiology Reviews 18, no 1 (janvier 2005) : 217–45. http://dx.doi.org/10.1128/cmr.18.1.217-245.2005.
Kapoor, Amit, Morris Jones, R. W. Shafer, Soo-Yon Rhee, Powel Kazanjian et Eric L. Delwart. « Sequencing-Based Detection of Low-Frequency Human Immunodeficiency Virus Type 1 Drug-Resistant Mutants by an RNA/DNA Heteroduplex Generator-Tracking Assay ». Journal of Virology 78, no 13 (1 juillet 2004) : 7112–23. http://dx.doi.org/10.1128/jvi.78.13.7112-7123.2004.
Hué, Stéphane, Robert J. Gifford, David Dunn, Esther Fernhill et Deenan Pillay. « Demonstration of Sustained Drug-Resistant Human Immunodeficiency Virus Type 1 Lineages Circulating among Treatment-Naïve Individuals ». Journal of Virology 83, no 6 (21 janvier 2009) : 2645–54. http://dx.doi.org/10.1128/jvi.01556-08.
Vergne, Laurence, Martine Peeters, Eitel Mpoudi-Ngole, Anke Bourgeois, Florian Liegeois, Coumba Toure-Kane, Souleymane Mboup et al. « Genetic Diversity of Protease and Reverse Transcriptase Sequences in Non-Subtype-B Human Immunodeficiency Virus Type 1 Strains : Evidence of Many Minor Drug Resistance Mutations in Treatment-Naive Patients ». Journal of Clinical Microbiology 38, no 11 (2000) : 3919–25. http://dx.doi.org/10.1128/jcm.38.11.3919-3925.2000.